Timely Disclosure

Timely Disclosure

Updates and Commentary on Current issues in M&A, Corporate Finance and Capital Markets

Tag Archives: Food and Drug Administration

The U.S. Government Shutdown: Ripple Effects North of the Border

Posted in Cross-Border, Securities Regulatory Authorities
Now in its fifth week, the U.S. federal government shutdown has become the longest in U.S. history. The partial shutdown began on December 22, 2018, following a stalemate between Congress and President Donald Trump over funding for a wall at the Mexican border. Many government services and agencies have been halted: NASA, the Smithsonian museums,… Continue Reading

Theratechnologies’ victory before the Supreme Court of Canada is a victory for all public corporations

Posted in Continuous & Timely Disclosure, Corporate Governance, Securities
The Supreme Court has handed down a judgment that marks a tremendous victory for Theratechnologies and public corporations in general. This important decision is a reminder of the continuous disclosure requirements of corporations and clearly defines the burden to be met by investors seeking authorization to bring a class action under the secondary market liability… Continue Reading